|
| Index | - | P/E | - | EPS (ttm) | -0.67 | Insider Own | 1.10% | Shs Outstand | 88.26M | Perf Week | -21.71% |
| Market Cap | 3.23B | Forward P/E | 72.41 | EPS next Y | 0.27 | Insider Trans | 0.00% | Shs Float | 35.31M | Perf Month | -29.76% |
| Income | - | PEG | - | EPS next Q | 0.04 | Inst Own | 84.60% | Short Float | 4.45% | Perf Quarter | -50.67% |
| Sales | 156.80M | P/S | 20.62 | EPS this Y | -40.60% | Inst Trans | -1.30% | Short Ratio | 2.91 | Perf Half Y | - |
| Book/sh | 7.85 | P/B | 2.45 | EPS next Y | 129.31% | ROA | - | Target Price | 44.11 | Perf Year | - |
| Cash/sh | 1.13 | P/C | 17.04 | EPS next 5Y | 62.31% | ROE | - | 52W Range | 19.17 - 50.30 | Perf YTD | -29.53% |
| Dividend | - | P/FCF | 129.33 | EPS past 5Y | - | ROI | -0.90% | 52W High | -59.77% | Beta | - |
| Dividend % | - | Quick Ratio | 2.20 | Sales past 5Y | - | Gross Margin | 68.70% | 52W Low | 5.56% | ATR | 1.83 |
| Employees | 560 | Current Ratio | 2.20 | Sales Q/Q | 43.20% | Oper. Margin | - | RSI (14) | 27.91 | Volatility | 7.88% 6.51% |
| Optionable | Yes | Debt/Eq | 0.39 | EPS Q/Q | - | Profit Margin | - | Rel Volume | 1.33 | Prev Close | 19.26 |
| Shortable | Yes | LT Debt/Eq | 0.38 | Earnings | Nov 08 AMC | Payout | - | Avg Volume | 540.04K | Price | 20.24 |
| Recom | 2.30 | SMA20 | -20.47% | SMA50 | -31.70% | SMA200 | -41.77% | Volume | 184,314 | Change | 5.06% |
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Definitive Healthcare Corp., through its software as a service platform, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 14 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device (life sciences) companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is based in Framingham, Massachusetts. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| open in yahoo | open in reuters | open in marketwatch | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite